QIAGEN Gets FDA Clearance for Respiratory Syndromic Test Panel
QIAGEN’s QIAstat-Dx Respiratory Panel Plus, a syndromic testing tool for diagnosing respiratory infections, received FDA clearance.
Read MorePosted by Andy Lundin | May 13, 2024 | Flu & Respiratory Infections |
QIAGEN’s QIAstat-Dx Respiratory Panel Plus, a syndromic testing tool for diagnosing respiratory infections, received FDA clearance.
Read MorePosted by Andy Lundin | May 1, 2024 | Miscellaneous |
Concert broadened its diagnostic benefit program to enhance payment and clinical policies and payment accuracy capabilities for lab testing.
Read MorePosted by Andy Lundin | Apr 30, 2024 | Cardiovascular |
Researchers developed a genetic testing procedure that can identify patients at high risk for cardiovascular diseases.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Disease States |
The FDA approved Labcorp’s companion diagnostic test designed to determine eligibility for Pfizer’s gene therapy for hemophilia B patients.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Molecular Diagnostics |
GenomOncology announced enhancements to its Pathology Workbench software, which features improved support for germline and somatic testing.
Read More